REQUEST A DEMO
Total
USD $0.00
Search more companies

Magnofarma Sas (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Pharmacies and Drug Stores | All Other Professional, Scientific, and Technical Services
Full name: Magnofarma Sas Profile Updated: April 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Magnofarma Sas is an enterprise located in Colombia, with the main office in Bogota D.C.. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on August 28, 1998. There are currently 14 (2025) people employed by Magnofarma Sas. There was a net sales revenue drop of 10.97% reported in Magnofarma Sas’s latest financial highlights for 2024. Its’ total assets recorded a negative growth of 10.68%. Magnofarma Sas’s net profit margin increased by 34.97% in 2024.

Headquarters
Calle 85 A 22 A 64
Bogota D.C.; Bogota D.C; Postal Code: 0817

Contact Details: Purchase the Magnofarma Sas report to view the information.

Basic Information
Total Employees:
Purchase the Magnofarma Sas report to view the information.
Registered Capital:
Purchase the Magnofarma Sas report to view the information.
Financial Auditors:
Purchase the Magnofarma Sas report to view the information.
Incorporation Date:
August 28, 1998
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Alternate Fiscal Auditor
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Magnofarma Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-10.97%
Total operating revenue
19.56%
Operating profit (EBIT)
576.32%
EBITDA
203.1%
Net Profit (Loss) for the Period
1028.12%
Total assets
-10.68%
Total equity
-8.39%
Operating Profit Margin (ROS)
35.46%
Net Profit Margin
34.97%
Return on Equity (ROE)
-71.3%
Debt to Equity Ratio
0.94%
Quick Ratio
0.33%
Cash Ratio
0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?